Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Dry Eye Treatment Devices Market, by Technology
1.4.2 North America Dry Eye Treatment Devices Market, by End User
1.4.3 North America Dry Eye Treatment Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Dry Eye Treatment Devices Market by Technology
3.1 North America Meibomian Gland Expression (MGX) Market by Country
3.2 North America Broadband light (BBL) Market by Country
3.3 North America Intense Pulsed Light (IPL) Market by Country
3.4 North America Combination (MGX+IPL) Market by Country
Chapter 4. North America Dry Eye Treatment Devices Market by End-use
4.1 North America Ophthalmic Clinics Market by Country
4.2 North America Hospitals Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Dry Eye Treatment Devices Market by Country
5.1 US Dry Eye Treatment Devices Market
5.1.1 US Dry Eye Treatment Devices Market by Technology
5.1.2 US Dry Eye Treatment Devices Market by End-use
5.2 Canada Dry Eye Treatment Devices Market
5.2.1 Canada Dry Eye Treatment Devices Market by Technology
5.2.2 Canada Dry Eye Treatment Devices Market by End-use
5.3 Mexico Dry Eye Treatment Devices Market
5.3.1 Mexico Dry Eye Treatment Devices Market by Technology
5.3.2 Mexico Dry Eye Treatment Devices Market by End-use
5.4 Rest of North America Dry Eye Treatment Devices Market
5.4.1 Rest of North America Dry Eye Treatment Devices Market by Technology
5.4.2 Rest of North America Dry Eye Treatment Devices Market by End-use
Chapter 6. Company Profiles
6.1 Lumenis Ltd.
6.1.1 Company Overview
6.1.2 Recent strategies and developments:
6.1.2.1 Approval:
6.2 Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental &Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 Alcon, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.3.5.2 Acquisitions:
6.4 Sight Sciences, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 MiBo Medical Group
6.5.1 Company Overview
6.6 ESW vision SAS
6.6.1 Company Overview
Unique Offerings 